Skip to main content

My account

Boston Scientific accounts are for healthcare professionals only.

Create an account to access online training and education on EDUCARE, manage your customer profile, and connect with customer support and service teams.

My Boston Scientific account

Access your online applications and manage your customer profile.

Manage my Boston Scientific account

Quick Links

Contact a representative
Online education and training
Order products online
Order lookup
Reimbursement resources
Customer support

Call customer care

1 (888) 272-1001

Healthcare professional reversing blood flow with the use of the Enroute Transcarotid Neuroprotection System during a carotid artery stenting procedure.

ENROUTE™ Transcarotid Neuroprotection System

Insights from Leading Vascular Surgeons

Advances in carotid intervention are changing what’s possible for patients and surgeons alike.

Hear directly from vascular surgeons as they describe how modern, minimally invasive approaches have expanded treatment options, reduced recovery burden, and elevated the standard of care for carotid disease.

Brant Ullery, MD, MBA, FSVS, FACS: Advancing Carotid Care Through Teamwork and Precision

TCAR has transformed how we care for complex carotid patients—making treatment safer, more collaborative, and more personalized than ever before.
– Brant Ullery

At a high-volume referral center, TCAR has reinvigorated multidisciplinary collaboration and expanded treatment options for high-risk patients. With predictable outcomes, strong neuroprotection, and dramatically faster recovery, TCAR has become the dominant carotid strategy—allowing patients to return to normal life quickly while preserving quality of life.

Caitlin Hicks, MD, MS: A Patient-Centered Alternative That Changes the Equation

TCAR gives us a third option—one patients clearly prefer and one that fits both high- and standard-risk cases.
– Caitlin Hicks

By combining minimal invasiveness with strong cerebral protection, TCAR has reshaped carotid decision-making. Patients consistently report faster recovery and better experiences compared to open surgery, while surgeons gain flexibility to treat even critically ill patients—often under local anesthesia—when other options fall short.

Michael Stoner, MD: Scalable, Reproducible Excellence Across Any Care Setting

TCAR allows us to deliver academic-level carotid outcomes—safely and consistently—across both tertiary centers and community hospitals.
– Michael Stoner

Built on deep academic study and real-world experience, TCAR has enabled reliable, sub‑1% stroke outcomes1,2 across diverse patient populations3. Its reproducibility, robust neuroprotection, and broad applicability have extended lifesaving carotid care to patients once considered ineligible—without compromising safety or results.

References:

1. Kashyap VS, et al. One-year outcomes after transcarotid artery revascularization (TCAR) in the ROADSTER 2 trial. J Vasc Surg. 2022 Aug;76(2):466-473.e1. doi: 10.1016/j.jvs.2022.03.872. Epub 2022 Apr 2. PMID: 35381327.
2. Jim, J. et al. (2025). Prospective, Multicenter Evaluation of Transcarotid Artery Revascularization in Standard-Risk Patients: 30-Day Outcomes from the ROADSTER 3 Study. Annals of Neurology. Advance online publication. https://doi.org/10.1002/ana.78104
3. Data on file at Boston Scientific.